[siRNA疗法:当前的选择和前景]
Cyril Neftel1, Darius Moradpour1
1Service de gastroentérologie et d'hépatologie, Centre hospitalier universitaire vaudois et Université de Lausanne, 1011 Lausanne.
Revue medicale suisse
|August 31, 2023
概括
小干扰RNA (siRNA) 疗法为遗传疾病提供有针对性的基因沉默. 传递方面的进步,特别是肝细胞的传递,突出了它们在肝病学及其他领域的治疗潜力.
科学领域:
- 生物医学研究的研究.
- 制药行业 制药行业 制药行业
- 基因治疗是一种基因疗法.
背景情况:
- 人们越来越了解遗传疾病,这导致了新的治疗策略.
- 基因疗法旨在通过调节基因表达来纠正遗传疾病.
- 小干扰RNA (siRNA) 是针对向基因抑制的有前途的治疗类.
研究的目的:
- 阐明siRNA疗法的作用机制.
- 审查目前的siRNA治疗方法及其临床应用.
- 探索siRNA的新兴和未来的治疗可能性.
主要方法:
- 关于siRNA技术和基因治疗的科学文献的综述.
- 分析siRNA传递系统的进步,包括脂质纳米粒子和化学修饰.
- 检查目前和正在研究的基于siRNA的治疗方法.
主要成果:
- siRNA疗法专门针对和抑制基因表达.
- 在向肝细胞输送siRNA方面取得了重大进展.
- 现有和正在开发的siRNA治疗方法对各种疾病有前途.
结论:
- siRNA技术是一个快速发展的领域,具有显著的治疗潜力.
- 向向肝细胞输送是siRNA疗法开发的一个关键领域.
- 未来的研究可能会扩大siRNA疗法的应用范围,使其适用于更广泛的疾病.
相关概念视频
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Small interfering RNAs (siRNA)
3.6K
3.6K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
Microorganisms in Medicine and Therapeutics
53
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
53
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K


